Patient dumping
Patient dumping is a term used in the United States to describe a situation where hospitals, in violation of the Emergency Medical Treatment and Active Labor Act (EMTALA), transfer, discharge, or refuse to treat indigent patients seeking emergency medical assistance because they are unable to pay, do not have insurance, or have a high-cost medical condition.
History[edit]
The term "patient dumping" was first used in the 1980s to describe a practice of private hospitals refusing to treat uninsured patients and transferring them to public hospitals. This practice led to the passage of the EMTALA in 1986, which prohibits patient dumping.
Legal aspects[edit]
Under the EMTALA, hospitals are required to provide a medical screening examination to any individual who comes to the emergency department and requests such an examination. If the hospital determines that the individual has an emergency medical condition, it must either stabilize the condition or transfer the patient to another hospital that can. Hospitals that violate the EMTALA can be subject to civil penalties and can be sued by patients who are harmed as a result of the violation.
Impact[edit]
Patient dumping can have serious consequences for patients, who may not receive the care they need in a timely manner. It can also place a significant burden on public hospitals, which are often less equipped to handle a large influx of patients.
See also[edit]
- Emergency Medical Treatment and Active Labor Act
- Healthcare in the United States
- Health insurance in the United States
References[edit]
-
260th Soldiers Stand Down for Homelessness
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
